CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity
Ontology highlight
ABSTRACT: CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity
PROVIDER: PRJNA670002 | ENA |
REPOSITORIES: ENA
ACCESS DATA